Kim, J., Kim, H., Hong, J. Y., Lee, J., Park, S. H., Park, J. O., . . . Kim, S. T. (2021). Prognostic Factors of Survival with Aflibercept and FOLFIRI (fluorouracil, leucovorin, irinotecan) as Second-line Therapy for Patients with Metastatic Colorectal Cancer. J Cancer.
Chicago Style citaatKim, Jinchul, et al. "Prognostic Factors of Survival With Aflibercept and FOLFIRI (fluorouracil, Leucovorin, Irinotecan) As Second-line Therapy for Patients With Metastatic Colorectal Cancer." J Cancer 2021.
MLA citatieKim, Jinchul, et al. "Prognostic Factors of Survival With Aflibercept and FOLFIRI (fluorouracil, Leucovorin, Irinotecan) As Second-line Therapy for Patients With Metastatic Colorectal Cancer." J Cancer 2021.
Let op: Deze citaties zijn niet altijd 100% accuraat.